Skip to main content

News

You are here

September 2014 Archive

UMB Champions Ad Features Gliknik Co-Founder & UM School of Medicine Faculty Member Scott Strome, M.D., FACS

Fighting Head and Neck Cancer: It was an offer he couldn’t refuse. After all, it came from his dad. And saying “yes” began Scott Strome’s extraordinary career in translational research. Read more about Dr. Strome, the company he co-founded, and why he is a UM Baltimore Champion of Excellence.

The InvestMaryland Challenge Returns with 100K Top Prize

Maryland’s national business competition the InvestMaryland Challenge is back for its third year. Hosted by the Maryland Department of Business and Economic Development, the Challenge will award $400,000 in grants and a host of business services to companies in the life sciences and high tech... read more

UMV Congratulates Tokai Pharmaceuticals on Pricing of Initial Public Offering

Read the news article from FierceBiotech and the company's news release for more information about Tokai's latest milestone: http://www.fiercebiotech.com/story/tokai-pockets-97m-ipo-cash-get-its-cancer-drug-phase-iii/2014-09-17?utm_medium=nl&utm_source=internal http://investors.tokaipharma.com/... read more

Harpoon Medical, Inc. Announces $3.75M Series A Financing

STEVENSVILLE, Md., Sept. 10, 2014 /PRNewswire/ -- Harpoon Medical, Inc., a medical device company focused on the development and commercialization of a minimally invasive, beating heart mitral valve repair technology, announced today that the company has successfully raised $3.2M of new capital... read more

BaltSun: Prostate Cancer Drug Shows Great Promise

Compound created at University of Maryland now in clinical trials A white powdered chemical compound emerged from two University of Maryland School of Medicine laboratories more than 10 years ago with a name destined for oblivion, but a future that now looks promising as a treatment for the most... read more